Data-based regression models for predicting remifentanil pharmacokinetics.

Area of Science:

• Pharmacology
• Data Science
• Anesthesiology

Background:

• Remifentanil is an ultra-short-acting opioid analgesic used intravenously for pain management during surgery.
• Individualized dosing is crucial but complex due to patient-specific factors.
• Traditional pharmacokinetic and pharmacodynamic (PK-PD) models often require manual parameter selection.

Purpose of the Study:

• To investigate supervised machine learning (ML) methods for analyzing remifentanil's pharmacokinetic characteristics.
• To develop predictive models for drug concentration based on patient data.
• To compare ML model performance against conventional PK-PD models.

Main Methods:

• Utilized supervised machine learning algorithms.
• Extracted patient features (age, gender, infusion rate, body surface area, lean body mass) from the Kaggle database.
• Trained models to predict remifentanil concentration at specific time points.
• Optimized model hyperparameters using Bayesian methods.

Main Results:

• Machine learning models demonstrated superior accuracy compared to traditional PK-PD models.
• Achieved a minimum mean squared error (MSE), indicating high prediction precision.
• Bayesian optimization significantly enhanced model performance.

Conclusions:

• Supervised ML offers a more accurate approach to predicting remifentanil pharmacokinetics.
• Optimized ML models can improve target-controlled drug delivery systems.
• Application of ML in drug delivery can reduce costs and experimental time in the pharmaceutical industry.